Who We Are

Monitors policies that impact the prevention and treatment of HIV, viral hepatitis, and other health conditions in the United States.
Communicates with members of the HIV, hepatitis, and other patient group communities on key policy issues that impact their access to healthcare.
Educates policymakers and members of the media about efforts to end both HIV and hepatitis in the United States and to improve access to quality and affordable healthcare for people with or at risk of serious or chronic health conditions.
Key Issues
Causes We Care About, and So Should You!

HIV
Promote necessary funding, programs, and policies to end the HIV epidemic in the United States

HEPATITIS
Promote necessary funding, programs, and policies to end viral hepatitis in the United States

HEALTHCARE ACCESS
Promote necessary funding, programs, and policies to end viral hepatitis in the United States
Facebook posts by @HIV+Hep
The Business Sector's Advocacy to Maintain Funding for HIV Prevention, Research, Treatment
www.contagionlive.com
A coalition of employers, the US Business Action to End HIV, sent a letter to Congress outlining the continued need for support from the federal government.www.gilead.com
First Clinical Data for Gileads Investigational Once Yearly Lenacapavir for HIV Prevention Presented at CROI 2025 and Published in The LancetLGBTQ Agenda: HIV organizations sounding the alarm as PrEP coverage case reaches SCOTUS
www.ebar.com
Several health advocacy and LGBTQ organizations are urging the United States Supreme Court to uphold coverage and zero cost-sharing for PrEP for HIV prevention.www.marshall.senate.gov
Washington – U.S. Senator Roger Marshall, M.D. (R-Kansas) and U.S. Senator Tim Kaine (D-Virginia) led their colleagues in introducing the Help Ensure Lower Patient (HELP) Copays Act. This legisla...